Completed OBSERVATIONAL NCT02384837

Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up

Effect of TCFA on Neointimal Coverage After EXCEL Biodegradable Polymer-coated Sirolimus-eluting Stents Implantation at 9 Months Follow-up: Evaluated by Optical Coherence Tomography and Fractional Flow Reserve

Sponsor: General Hospital of Chinese Armed Police Forces

Conditions Unrecognized Condition

Interventions EXCEL biodegradable polymer-coated sirolimus-eluting stent

Updated 6 times since 2017 Last updated: Dec 4, 2016 Started: Dec 31, 2014 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02384837, this observational or N/A phase trial focuses on Unrecognized Condition and remains completed. Sponsored by General Hospital of Chinese Armed Police Forces, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital of Chinese Armed Police Forces

Data source: General Hospital of Chinese Armed Police Forces

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China